Allogeneic Hematopoietic Cell Transplantation From HLA-matched Donor After Flu-Mel-PTCy Versus Flu-Mel-ATG Reduced-intensity Conditioning

Abroad (travel likely)RecruitingPHASE2

Conditions

Acute Myeloid Leukemia in Remission · Myelodysplastic Syndromes · Chronic Myeloid Leukemia in Remission · Myeloproliferative Syndrome · Myeloproliferative Disorder · Acute Lymphoid Leukemia in Remission · Multiple Myeloma · Chronic Lymphoid Leukemia · Non Hodgkin Lymphoma · Hodgkin Lymphoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

ZNA Stuivenberg, Antwerp, Belgium
Contact: Study coordinator (Dimitri Breems, MD PhD) · dimitri.Breems@zna.be
AZ Sint Jan Brugge, Bruges, Belgium
Contact: Study coordinator (Dominik Selleslag, MD, PhD) · dominik.selleslag@AZsintjan.be
IJ Bordet, Brussels, Belgium
Contact: Study coordinator (Philippe Lewalle, MD PhD) · philippe.lewalle@bordet.be
UZ Brussel, Brussels, Belgium
Contact: Study coordinator (Ann De Becker, MD PhD) · ann.debecker@uzbrussel.be
Rik Schots, MD PhD (Sub-investigator)
UCL St Luc, Brussels, Belgium
Contact: Study coordinator (Xavier Poiré, MD) · xavier.poire@uclouvain.be
UZ Gent, Ghent, Belgium
Contact: Study coordinator (Tessa Kerre, MD PhD) · t.Kerre@UGent.be
UZ Leuven, Leuven, Belgium
Contact: Study coordinator (Johan Maertens, MD PhD) · johan.maertens@uzleuven.be
Hélène Schoemans, MD PhD (Sub-investigator)
CHU de Liège, Liège, Belgium
Contact: Study coordinator (Frédéric Baron, MD, PhD) · F.Baron@uliege.be · +3243667201
Contact: Study coordinator (Yves Beguin, MD, PhD) · yves.beguin@chuliege.be · +3243667201
Evelyne Willems, MD (Sub-investigator)
Sophie Servais, MD (Sub-investigator)
AZ Delta Roeselare, Roeselare, Belgium
Contact: Study coordinator (Dries Deeren, MD) · dries.deeren@AZdelta.be
CHU UCL Namur Godinne, Yvoir, Belgium
Contact: Study coordinator (Carlos Graux, MD PhD) · carlos.graux@uclouvain.be

Study leads

Frédéric Baron, MD,Ph
Principal Investigator
Centre Hospitalier Universitaire de Liege

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Registry of Older Patients With Cancer

Chronic Myeloproliferative Disorders · Cognitive/Functional Effects · Leukemia

Abroad (travel likely)Recruiting

Boone, United States · Chapel Hill, United States

Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer

Chronic Myeloproliferative Disorders · Leukemia · Lymphoma

Abroad (travel likely)Recruiting

Chapel Hill, United States

3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer

Brain and Central Nervous System Tumors · Chronic Myeloproliferative Disorders · Leukemia

Abroad (travel likely)Recruiting

Detroit, United States

MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies

Hematologic Malignancy · Acute Leukemia · Remission

Abroad (travel likely)RecruitingPHASE2

Minneapolis, United States